SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-22-025322
Filing Date
2022-02-22
Accepted
2022-02-22 06:13:02
Documents
1
Group Members
CHEUNG KA HOFRANCES ANNE ELIZABETH RICHARDGOLWYN CAPITAL APPRECIATION LTDJILL MARIE FRANKLINULTIMATE KEEN LTDWONG YUK LAN

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm227035d1_sc13da.htm SC 13D/A 124934
  Complete submission text file 0001104659-22-025322.txt   126988
Mailing Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109
Business Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109 206-485-7051
CHINOOK THERAPEUTICS, INC. (Subject) CIK: 0001435049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88812 | Film No.: 22654807
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O THC MANAGEMENT SERVICES S.A.M. 2ND FLOOR, LE PRINCE DE GALLES 3-5 AVENUE DES CITRONNIERS O9 MC 98000
Business Address C/O THC MANAGEMENT SERVICES S.A.M. 2ND FLOOR, LE PRINCE DE GALLES 3-5 AVENUE DES CITRONNIERS O9 MC 98000 011 377 97-97-47-37
Morningside Venture (VI) Investments Ltd (Filed by) CIK: 0001636810 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D6 | Fiscal Year End: 1231
Type: SC 13D/A